The Portfolio Armor Substack

The Portfolio Armor Substack

Trade Alert: The China-Free Drone Bottleneck

A re-entry in UMAC after a profitable exit, plus new gene-therapy and enterprise-AI trades.

Portfolio Armor's avatar
Portfolio Armor
Sep 18, 2026
∙ Paid

A Tiny Part Can Stop A Weapons System

Taiwan recently received 291 Anduril Altius 600M loitering munitions without the charging equipment originally contemplated in the procurement package. The problem was prosaic and strategically important: the original chargers contained Chinese-made components, so they couldn’t be used in the program’s non-China supply chain.

Anduril has since developed a compliant charger for delivery. The episode still shows how difficult it is to build modern weapons without Chinese components. A drone is only one piece of a larger system that includes batteries, chargers, motors, controllers, sensors, and communications gear.

For investors, that bottleneck creates opportunity for domestic suppliers that can meet military sourcing requirements at scale.

How UMAC Came Onto Our Radar

A couple of months ago, one of our subscribers sent us a Zero Hedge report on Unusual Machines (UMAC 0.00%↑). It cited H.C. Wainwright analyst Amit Dayal’s view that UMAC was positioned for a “massive procurement tailwind” as demand grows for American-made, NDAA-compliant drone components.

The subscriber brought it to our attention because a month earlier, we had entered a trade in UMAC.

Trade Alert: Recycling Gains

Portfolio Armor
·
Jun 24
Trade Alert: Recycling Gains

Recycling Gains Into New Trades

Read full story

The stock had surfaced through our Market Watchers list, a curated group of investors and analysts on X whose market commentary we monitor for actionable ideas.

The original structure paired a call calendar with a $15/$10 put spread. The $1.78 credit from the put spread helped finance the $3.53 debit for the call calendar, bringing the complete position’s entry cost down to $1.75.

⁠We later exited the call calendar for an $8.00 net credit, producing a $447 profit on that component, or 127% on its $3.53 premium outlay. The November $15/$10 put spread remains open and well out-of-the-money.

Why We’re Reentering UMAC:

UMAC returned Thursday night as our #4 Portfolio Armor Top Name, with an estimated potential return of 56% over the next six months. It also passes our Trend & Consolidation, AI Profitable Recovery, and AI Speculative Recovery screens.

Portfolio Armor Top Names are the securities our system estimates will have the highest returns over the next six months. The March 12th Top Names cohort offers a recent example. Its average six-month return was 56.00%, versus 14.74% for SPY.

Screen capture via the Portfolio Armor iPhone app.

Today’s paid section contains the new UMAC trade, along with a gene-therapy setup positioned around pivotal 2027 data and an enterprise-AI leader whose latest quarter included >90% revenue growth. Each is an asymmetric bullish structure, and we’ve used multiple options pricing models to make sure we’re not overpaying for them.

New to our alerts? Start Here explains how we select trades, set entry prices and exits, and track every completed result.

Today’s Top Names Trade

Theme: China-free drone components and defense-industrial capacity.

RSI: 49 · Chartmill Technical: 7/10 · Setup: 6/10 · Fundamental: 4/10

User's avatar

Continue reading this post for free, courtesy of Portfolio Armor.

Or purchase a paid subscription.
© 2026 Portfolio Armor · Market data by Intrinio · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture